Short- and long-term (six-year) hemodynamic effects of labetalol in essential hypertension
- 17 October 1983
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 75 (4) , 24-31
- https://doi.org/10.1016/0002-9343(83)90133-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Role of beta-adrenergic blockade in the therapy of patients with myocardial infarctionThe American Journal of Medicine, 1983
- Acute and long-term effects of labetalol on systemic and pulmonary haemodynamics in hypertensive patientsEuropean Journal of Clinical Pharmacology, 1980
- Response of the systemic and pulmonary circulation to alpha- and beta-receptor blockade (labetalol) at rest and during exercise in hypertensive patients.Circulation, 1979
- Hemodynamic Consequences of Long-Term Beta-Blocker TherapyJournal of Cardiovascular Pharmacology, 1979
- Haemodynamic effects and plasma concentrations of labetalol during long‐ term treatment of essential hypertension.British Journal of Clinical Pharmacology, 1979
- Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol.Heart, 1979
- LabetalolDrugs, 1978
- Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.Circulation, 1977
- Labetalol (AH5158), a Competitive Alpha‐and Beta‐Receptor Blocking Drug, in the Management of HypertensionAustralian and New Zealand Journal of Medicine, 1976
- Beta adrenergic blockade in hypertension: Practical and theoretical implications of long-term hemodynamic variationsThe American Journal of Cardiology, 1972